Articles tagged with Viral Infections
Scientists have discovered two new strains of the HTLV-4 virus in hunters bitten by gorillas in Gabon, supporting the notion that gorillas are a major source of infectious agents. The findings suggest that gorilla bites can lead to chronic persistence of the virus in humans.
Researchers tested serum antibodies from Ebola survivors and found substantial cross-reactivity with other filoviruses, suggesting long-lived immunity. The study's results indicate that antibody responses extend beyond the primary virus, imparting at least partial immunity to other filoviral infections.
A new study suggests that a protein deficiency in spinal muscular atrophy (SMA) disrupts cellular endocytosis, leading to muscle weakness. Interestingly, a mild version of this defect may also confer resistance to infections in carriers of the disease.
A team of scientists developed a system that forecasts dengue fever outbreaks by analyzing citizens' calling behavior on public-health hotlines. The system achieved high accuracy in predicting disease cases and locations two to three weeks ahead.
Researchers at Stanford University School of Medicine developed a diagnostic test that can distinguish between bacterial and viral infections using just seven human genes. The seven-gene test is more accurate, cheaper, and faster than earlier tests, with the potential to reduce antibiotic misuse and save healthcare systems money.
Researchers found that viral hepatitis is now a leading cause of death and disability globally, killing at least 1.45 million people annually, surpassing TB, malaria, and HIV/AIDS. The disease burden is more evenly divided between high- and low-income countries.
A recent study reveals that bacteriophage PAK_P3 degrades bacterial RNAs and scavenges pyrimidine nucleotides to replicate. This finding highlights the prominent role of RNA metabolism in phage infection, offering a new understanding of phage therapy's potential.
A new study found that reducing antibiotic prescribing for respiratory tract infections does not increase the risk of serious bacterial complications. However, it also suggests that practices with lower rates of antibiotic prescribing had slightly higher rates of pneumonia and peritonsillar abscess.
A team of researchers from Hokkaido University found that a receptor, known for its role in mediating dioxin toxicity, also regulates the body's innate immune response to viral infections. The activation of this receptor negatively regulates the production of an antiviral protein called type I interferon.
New research found that CD4 T-cells in young mice secrete lower levels of interferon gamma, a key antiviral cytokine, leading to higher rates of immune cell death and delayed virus clearance. This may explain children's increased susceptibility to illnesses.
Researchers will study immune responses of 200 volunteers with diagnosed or symptomatic Zika, analyzing blood specimens to understand body's response. Understanding natural history and immune system could identify targets for treatments and vaccines.
The Baylor College of Medicine has been awarded over $1 million from the National Institutes of Health to lead a study on people infected with Zika virus. The study aims to inform diagnostic and infection control measures, as well as Zika vaccine development.
Researchers developed a fast and non-destructive method to detect Wolbachia bacteria in Aedes mosquitoes using near-infrared spectroscopy. The technique shows high accuracy in detecting the presence of Wolbachia strains, including benign and aggressive forms, with an average accuracy of 96-92%.
Researchers found that microcephaly screening alone is insufficient to detect all cases of Zika virus in newborns. The study suggests that signs and symptoms of brain abnormalities should also be included in screening criteria.
Research funded by NIAID found that Zika virus lingers in pregnant animals for at least 57 days, but provides immunity against future infections. Non-pregnant monkeys cleared the virus within 10 days of infection.
Researchers at Children's Hospital of Philadelphia discovered a novel mechanism by which viruses shut down alarm signals that trigger immune responses. By trapping an important signaling molecule inside the cell nucleus, viral protein VII prevents it from sounding an alarm to the immune system.
A new portable test has been developed to detect the Zika virus in saliva for just $2, making it a promising tool for managing outbreaks. The test can accurately detect low levels of the virus and distinguish it from similar viruses like dengue.
A University of Miami research team created a mathematical model to investigate the role of sexual transmission in the spread and control of Zika. The study found that mosquito control remains the most important mitigation method, but sexual transmission increases the risk of infection and prolongs outbreaks.
A recent NIH-supported study pinpoints the origin of the 2009 H1N1 influenza pandemic in central Mexico, where it emerged from pigs before spreading to humans. The research highlights the importance of tracking swine populations and understanding how economic factors contribute to viral outbreaks.
Two experimental Zika vaccines fully protected mice from infection, even after four weeks without inoculation. The DNA and inactivated virus vaccines induced virus-specific antibodies, correlating with protection against infection.
A Weizmann Institute study found that viral infection during pregnancy disrupts the fetal immune system, leading to abnormal brain development and increased risk of neurodevelopmental disorders. The study suggests a possible explanation for how maternal infections raise the risk of autism and schizophrenia in offspring.
Scientists have found that antibodies developed in response to dengue virus can cross-react with and neutralize Zika virus, but also enhance its infection in laboratory experiments. These findings suggest a complex relationship between the two viruses and offer potential insights for vaccine design and treatment.
Researchers have discovered two antibodies that can efficiently neutralize both dengue and Zika viruses, sharing identical binding sites on their viral envelopes. This breakthrough could lead to the development of a single vaccine offering protection against both diseases.
Researchers found MAIT cells can bypass specific receptors to react to cytokine combinations, previously only known for fighting bacteria. The discovery suggests MAIT cells could be involved in defending against or reducing the effects of viruses.
A study from Imperial College London found that previous exposure to the dengue virus may increase the potency of Zika infection, potentially leading to more severe symptoms. The research suggests that the Zika virus uses the body's own defences as a 'Trojan horse', allowing it to enter human cells undetected and replicate rapidly.
A new study reveals that a single gene can drive prostate differentiation in seminal vesicle epithelial cells, suggesting potential insights into prostate cancer development. The research found that inducing expression of the Nkx3.1 gene caused seminal vesicle cells to convert into a prostate-like state.
Researchers identified that West Nile virus may cause long-term neurological problems like memory loss by over-activating the immune system in the brain. The study suggests that intervening in this immune response may help prevent brain damage or aid recovery.
West Nile virus causes memory loss and mood disorders by sparking inflammation that prunes synapses, the connections between nerve cells. Researchers have identified potential new treatments for the mosquito-borne illness.
Researchers found that mosquito bites can facilitate viral replication and spread by triggering an inflammatory response in the skin. The study suggests new approaches for combating viruses, including using topical creams to suppress bite inflammation.
The National Institutes of Health has launched a multi-country study to investigate the health risks associated with Zika virus infection during pregnancy. The study aims to enroll up to 10,000 pregnant women across several locations affected by Zika outbreaks, followed throughout their pregnancies and into early childhood.
Researchers found that mosquito bites enhance the replication of viral infections like Zika and dengue by triggering an inflammatory response in the body. Anti-inflammatory medications may be effective in stopping this process and preventing severe illness.
The Zika virus outbreak has highlighted the need for new paradigms in child health, requiring mobilization by pediatricians and healthcare providers to address the growing number of cases. The article suggests revisiting the response to HIV/AIDS 30 years ago to inform a new approach.
Researchers have developed a method using tiny alpaca-derived nanobodies to identify and target specific proteins involved in viral infections. By using these molecules to perturb cellular processes, scientists can tease apart the roles individual proteins play in disease, leading to potential new treatments for infectious diseases.
Researchers at Sandia National Laboratories have discovered that the Rift Valley fever virus uses the Wnt signaling pathway to hijack host machinery and cause infection. This mechanism offers a promising new target for developing therapeutics against this deadly virus, which can cause fatal hepatitis and hemorrhagic fever.
Researchers found that mosquito saliva increases endothelial permeability, enhances immune cell migration, and promotes the spread of dengue virus during antibody-dependent enhancement. This study suggests a critical role of mosquito saliva in exacerbating dengue disease severity.
Zika virus is likely transmitted through blood transfusions, prompting calls for evidence-based approach to protect the blood supply. Researchers recommend deferring donors with symptoms, developing better screening tests, and reducing pathogen transmission.
A virus has been found to use a 'stolen' CRISPR system to hijack its host's immune response, allowing it to fight off other viral infections. The Cyanophage N1 virus uses a CRISPR sequence typically used by bacteria to defend against viruses.
Researchers from Umeå University warn that parts of Southern Europe are at risk for Zika outbreaks between June and August. The study found that the presence of established Aedes-mosquito populations, warmer temperatures, and peak air traveler flows make Southern Europe a fertile ground for Zika transmission.
New research suggests that sexual transmission of Ebola could have a major impact on the dynamics of the disease. The study found that even small and short outbreaks with sexual transmission were larger and longer-lasting than those without it.
Researchers found that Zika virus infects about 20% of brain progenitor cells, which can become neurons, and continues to replicate for weeks without stimulating an immune response. The study provides insights into the severe neurological effects caused by Zika, such as microcephaly and impaired growth in infants.
Researchers predict a low risk of dengue infection among foreign visitors to the Rio Olympics, with estimates suggesting as few as three symptomatic cases and potentially no asymptomatic infections at all. The predictions are based on sophisticated mathematical modeling techniques and data from Brazil's Health Ministry.
A new study found that viral infections during pregnancy can lead to abnormal fetal brain development, increasing the risk of conditions like autism and schizophrenia. By manipulating serotonin levels, researchers were able to normalize fetal forebrain development and reduce this risk.
Researchers found that human activities drive disease distributions at local scales for diseases like West Nile virus and Lyme disease, while climate change impacts regional scales. The study highlights the importance of considering multiple spatial scales to understand human ecological impacts on biodiversity and disease emergence.
Researchers identified a type of skin cell as the target of the virus in humans and found that an FDA-approved drug can block viral infection. The study establishes a new way to investigate this type of oncogenic viral infection and provides hope for better treatments.
A new tool by Japanese researchers predicts the risk of Zika virus importation and local transmission for 189 countries, identifying subtropical and tropical nations as high-risk. Countries with a history of dengue and other mosquito-borne diseases face the greatest risk of infection.
Researchers found that Zika virus can infect human placental macrophages, known as Hofbauer cells, which have direct access to fetal blood vessels. This infection may allow the virus to cross the placental barrier and enter the fetal circulation, posing a risk to fetal development.
A study published in JAMA Ophthalmology identified risk factors for ophthalmoscopic findings in infants born with microcephaly and presumed Zika virus infection. Infants with smaller head diameters at birth and those whose mothers reported symptoms during the first trimester were more likely to have ocular involvement.
A dengue vaccine has the potential to substantially reduce disease burden if it induces long-lasting immunity. Researchers found that a durable vaccine, with booster doses, can reduce annual dengue incidence by up to 80% within five years.
A new study has found that the Zika virus is linked to a range of eye problems in Brazilian babies born with microcephaly. The researchers observed retinal lesions, hemorrhaging, and abnormal blood vessel development in three infants, which could result in severe visual impairment if left untreated.
Researchers at the University of Oklahoma Health Sciences Center are working to develop a vaccine for the Zika virus, using their experience with West Nile virus. They aim to identify specific parts of the virus that can be targeted by the immune system, and have received $230,000 in NIH funding for their research.
A team of scientists analyzed multiple studies on three well-known viral families to understand how viruses evolve and increase their genetic diversity. They found that segmented RNA viruses can replicate with a single parental line, but reassortment between viruses is limited by physical and molecular constraints.
A new tool helps guide resource allocation for Zika virus interventions by analyzing health impact and costs. The tool suggests that proposed funds to combat Zika in the US and other countries would be cost-effective, particularly for measures reducing Zika infections.
Scientists have successfully obtained a high-resolution image of the Zika virus helicase, a key target for antiviral development. The structural information will help researchers design and develop effective small-molecule inhibitors to stop viral replication and prevent disease.
Researchers at Mount Sinai Hospital have developed a strategy to create the first broad-spectrum antiviral drug, which could provide protection against seven deadly viruses, including Nipah and Ebola. By targeting a single gene, the approach boosts immunity against viral infections.
A simple paper sheet can remove resistant viruses from water, improving access to safe drinking water for millions. The mille-feuille filter uses cellulose nanofibers and has a unique layered internal architecture.
Researchers found that a mutation in the protein shell of the John Cunningham polyomavirus can affect the immune system's response to the infection, leading to progressive multifocal leukoencephalopathy. This discovery may help prevent the disease in autoimmune patients on immunosuppressant therapies.
Researchers have identified an experimental antiviral drug that slows down Zika virus development in mice. The study suggests the drug may provide protection against Zika-induced symptoms and microcephaly in pregnant women.
Researchers genetically engineered a Zika virus infectious cDNA clone, enabling rapid vaccine development and exploration of the virus's evolution and transmission. The study unlocks insights into why the Zika virus causes severe diseases and epidemics.
A review article by J. David Beckham highlights Zika virus's impact on global health, emphasizing the need for ongoing research to develop a viable vaccine and treatment options. The article notes that exposure avoidance through insect repellent and protective measures is currently the best approach to prevent complications.
Researchers identified two existing compounds effective against the Chikungunya virus in an animal model, bringing a potential treatment within reach. The findings also suggest that these compounds may be useful for broadly acting antivirals against emerging viruses.